Literature DB >> 7627716

Upregulation of connexin43 gap junctions during early stages of human coronary atherosclerosis.

J P Blackburn1, N S Peters, H I Yeh, S Rothery, C R Green, N J Severs.   

Abstract

Interactions between cells form the framework for understanding the pathogenesis of atherosclerosis, but little information is available on the role of direct intercellular communication via gap junctions in this process. To investigate gap junction expression in the pathogenesis of human atherosclerosis, lesions representing different stages of the disease were obtained from coronary arteries of hearts removed from patients undergoing cardiac transplantation. Twelve hearts, each providing 1 to 3 segments of artery, were used in the study. Sections were examined by confocal laser scanning microscopy after immunofluorescent labeling with a specific antibody against connexin43, the major gap-junctional protein of smooth muscle cells, to permit high-definition visualization of immunolabeled gap junctions through the depth of the specimen. Double labeling using anti-connexin43 and cell type-specific antibodies demonstrated colocalization of gap junctions with smooth muscle cells but not with macrophages, a relationship confirmed by electron microscopy. Regions of intimal thickening and early atheromatous lesions showed markedly increased expression of connexin43 gap junctions between intimal smooth muscle cells compared with the undiseased vessels. This increase in gap junctions was most marked in regions of intimal thickening, semiquantitative analysis of the confocal digital images revealing a > 10-fold increase compared with the undiseased vessel. The quantity of labeled gap junctions in early atheromatous lesions, although higher than that of the undiseased vessel, was lower than that of intimal thickenings, and this trend toward reduced levels of gap junction immunolabeling with lesion progression continued, the value observed in the most advanced atheromatous lesions being lower than that of the undiseased vessel. As the quantity of gap junctions declined, their distribution became more patchy and the sizes of individual junctions larger. The results suggest that enhanced expression of gap junctions between smooth muscle cells may play a role in maintaining the synthetic phenotype during early growth of the atherosclerotic plaque.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7627716     DOI: 10.1161/01.atv.15.8.1219

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  23 in total

1.  Inhibition of endothelial wound repair by dominant negative connexin inhibitors.

Authors:  B R Kwak; M S Pepper; D B Gros; P Meda
Journal:  Mol Biol Cell       Date:  2001-04       Impact factor: 4.138

Review 2.  Candidate genes and confirmed genetic polymorphisms associated with cardiovascular diseases: a tabular assessment.

Authors:  Z Tang; R P Tracy
Journal:  J Thromb Thrombolysis       Date:  2001-02       Impact factor: 2.300

3.  Formation of heteromeric gap junction channels by connexins 40 and 43 in vascular smooth muscle cells.

Authors:  D S He; J X Jiang; S M Taffet; J M Burt
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

4.  Imaging cells and tissues with refractive index radiology.

Authors:  Y Hwu; W L Tsai; H M Chang; H I Yeh; P C Hsu; Y C Yang; Y T Su; H L Tsai; G M Chow; P C Ho; S C Li; H O Moser; P Yang; S K Seol; C C Kim; J H Je; E Stefanekova; A Groso; G Margaritondo
Journal:  Biophys J       Date:  2004-10-01       Impact factor: 4.033

5.  Differential endothelial gap junction expression in venous vessels exposed to different hemodynamics.

Authors:  Chi-Jen Chang; Lung-Sheng Wu; Lung-An Hsu; Gwo-Jyh Chang; Chin-Fen Chen; Hung-I Yeh; Yu-Shien Ko
Journal:  J Histochem Cytochem       Date:  2010-08-30       Impact factor: 2.479

Review 6.  Enteric Glial Cells: A New Frontier in Neurogastroenterology and Clinical Target for Inflammatory Bowel Diseases.

Authors:  Fernando Ochoa-Cortes; Fabio Turco; Andromeda Linan-Rico; Suren Soghomonyan; Emmett Whitaker; Sven Wehner; Rosario Cuomo; Fievos L Christofi
Journal:  Inflamm Bowel Dis       Date:  2016-02       Impact factor: 5.325

Review 7.  Gap junctions.

Authors:  Morten Schak Nielsen; Lene Nygaard Axelsen; Paul L Sorgen; Vandana Verma; Mario Delmar; Niels-Henrik Holstein-Rathlou
Journal:  Compr Physiol       Date:  2012-07       Impact factor: 9.090

Review 8.  Connexins in Cardiovascular and Neurovascular Health and Disease: Pharmacological Implications.

Authors:  Luc Leybaert; Paul D Lampe; Stefan Dhein; Brenda R Kwak; Peter Ferdinandy; Eric C Beyer; Dale W Laird; Christian C Naus; Colin R Green; Rainer Schulz
Journal:  Pharmacol Rev       Date:  2017-10       Impact factor: 25.468

Review 9.  Connexins participate in the initiation and progression of atherosclerosis.

Authors:  Sandrine Morel; Laurent Burnier; Brenda R Kwak
Journal:  Semin Immunopathol       Date:  2009-04-30       Impact factor: 9.623

10.  The anti-arrhythmic peptide AAP10 remodels Cx43 and Cx40 expression and function.

Authors:  Jennifer A Easton; Jorgen S Petersen; Patricia E M Martin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-03-27       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.